Brand name (Generic drug name)

BEOVU

Active Ingredient: brolucizumab

Drug Class: Ophthalmological / Antineovascularization Agents

This drug is not on the Reformulary. Our Expert Committee did an extensive review of the clinical and cost-effectiveness evidence, and recommended not to fund due to lack of evidence.